Clinical Psychopharmacology and Neuroscience 2020; 18(4): 641-641
Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
Changsu Han1, Sheng-Min Wang2,3, Won-Myong Bahk2, Soo-Jung Lee2, Ashwin A. Patkar4, Prakash S. Masand5, Laura Mandelli6, Chi-Un Pae2,4,7, Alessandro Serretti6
1Department of Psychiatry, Korea University College of Medicine, Seoul, 2Department of Psychiatry and 7Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, 3International Health Care Center, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, 4Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, 5Global Medical Education, New York, NY, USA, 6Department of Biomedical and Neuromotor Sciences, Psychiatric Section, University of Bologna, Bologna, Italy
Correspondence to: Chi-Un Pae
Department of Psychiatry, The Catholic University of Korea, Bucheon St. Mary’s Hospital, 327 Sosa-ro, Wonmi-gu, Bucheon 14647, Korea
Published online: November 30, 2020.
© The Korean College of Neuropsychopharmacology. All rights reserved.

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

The authors found inadvertent errors including typos in the above published paper. In the baseline comparison, typos are corrected and all items of categorical parameters are presented to ensure the proportion. P values are partly changed to correct oversight on statistics from Chi-square, Fisher’s exact test, and nonparametric test. As for comparison of continuous clinical outcomes between the two groups, there was an error in proper inclusion of covariates proposed in the original version. As for comparison of proportional outcomes between the two groups, there were subjects not included in the analysis (response comparison, 5 for PGATx and 9 for TAU; remission comparison, 7 for PGATx and 9 for TAU; CGI response comparison, 6 for PGATx and 2 for TAU; FIBSER comparison, 13 for PGATx and 18 for TAU). Therefore, the results of Tables 1/2 and Figures 2/3, and corresponding paragraphs within the text are all corrected. However, all corrected results are in line with the original outcomes without any directional changes and thus these corrections do not change the scientific conclusions of the paper in any way. The authors would like to deeply apologize for inadvertent errors that appeared in the paper.

A revised version of this paper containing the corrections noted above has been published as supplementary data (see uploaded file).

Supplementary Data: 1. Correction. 2. Corrected version of the originally published paper.

This Article